Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acid Therapy for GI Bleeding Prevention in CF-LVAD Patients
NCT03784963Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3 fatty acid in gastrointestinal bleeding, sponsored by University of Chicago. Started Jan 2019; status: terminated.
02
Drugs
omega-3 fatty acid
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT03784963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784963.